Natreon supports sports nutrition platform with more patents for botanical ingredients


02 Nov 2017 --- Natreon has announced its enhancement of its Natreon One sports nutrition portfolio with an increased selection of patents for botanical ingredients. These include US, Chinese and Japanese patents for a new bioactive isolated from Sensoril – an aqueous extract of ashwagandha – which cover the recent discovery of a new class of compounds, Indolealkylamino-withasteroid conjugates.

Additionally, the company has been granted a US patent for its Ayuric ingredient whose claims support the use of Ayuric, a standardized extract of Terminalia bellirica, for the treatment of gout, uricemia and hyperuricemia.

Finally, the Canadian patent office issued a patent for Natreon’s super antioxidant ingredient, Capros, a standardized extract of Phyllanthus emblica, which covers a composition and method to treat or prevent endothelial dysfunction.

Botanical patents bridging the gap
The additional issued patents, in line with Natreon’s new sports nutrition platform that bridges the gap between botanicals and science, support Natreon’s focus on investing in product innovation and clinical studies to support the ingredients it brings to market, the company states. The company debuted its Natreon One sports nutrition platform during this year’s SupplySide West.

“Natreon is proud to lead the industry in patented, scientifically validated botanicals with optimal levels of bioactives,” says Natreon President Bruce Brown, who joined the company in early 2017. “Natreon One is bridging the gap between botanical solutions and sports nutrition. This is an important yet underserved category for our industry and the announcement of Natreon One signals our continued investment in clinical research around our sports nutrition products, as well as our commitment to developing next-generation ingredients to enhance sports performance.”

Patents back up benefits
The patent entitled “Indolealkylamino-withasteroid conjugates and method of use” is labeled US 9,084,800 (Issued July 21, 2015), China 2440900 (Issued April 22, 2017), and JP 6144688 (Issued May 19, 2017). Natreon discovered a new class of compounds, Indolealkylamino-withasteroid conjugates, in ashwagandha (Withania somnifera) and these compounds showed significant acetylcholinesterase inhibitory activity in vitro and showed anti-Alzheimers’ activity in an ex vivo study done at Rowan University, New Jersey, US, using a pig retina model.

Sensoril, Natreon’s standardized aqueous botanical extract of Ashwagandha roots and leaves, “helps increase resistance to fatigue and boosts energy levels, supports healthy joints and mood, helps enhance focus and mental stamina, and supports sleep and stress reduction.”

In addition, the patent for Terminalia chebula and Terminalia bellirica for inhibition of xanthine oxidase is labeled US 9,750,778 and was issued on September 5. The allowed claims include the use of an aqueous extract of Terminalia bellirica, of a defined composition of bioactives, for the treatment of gout, uricemia and hyperuricemia.

In a randomized, double-blind, placebo-controlled clinical study done on Ayuric (Clinical Pharmacology: Advances and Applications 2016:8 51–59), Natreon’s Terminilia bellirica ingredient, Ayuric, was twice as effective as Termininalia chebula and 57 percent as effective as Febuxostat, a prescription product used to reduce uric acid levels in the blood. 
Patent CA 2,810,732, issued on July 18, is entitled “Compositions and method for improving endothelial function and cardiovascular health.” The primary claim is: “use of a composition to treat or prevent endothelial dysfunction in an individual, the composition comprises an extract of pulped Phyllanthus emblica and a pharmaceutically acceptable carrier, wherein endothelial function is improved.” This patent corresponds to US 8,962,576, issued in 2015.

Natreon markets this extract under the trade name Capros, a heart-healthy superfruit extract for endurance. Natreon asserts that it “boosts nitric oxide levels and supports healthy blood flow, significantly reduces hsCRP which leads to decreased inflammation and better recovery, and acts as a super-antioxidant to protect the body against oxidative stress.”

Related Articles

Nutrition & Health News

Dairy proteins take center stage at FiE 2017

12 Dec 2017 --- Exhibitors at FiE 2017 in Frankfurt showed a sustained focus on high protein concepts, with a number of notable innovations in the area of dairy-related ingredients. NutritionInsight looks at just a few of the offerings showcased at this year’s event.

Nutrition & Health News

Energetic growth: Energy boosters add pep to the nutritional space’s step

11 Dec 2017 --- Busy schedules can cause consumers to go through an “energy crisis” – prompting their desire to reach for products that might offer some support to their energy levels. Energy boosters are certainly showing signs of growth in all regions tracked by Innova Market Insights. A CAGR in supplement launches of +208.8 percent in South America from 2012 to 2016 is particularly noteworthy, while Europe is top of the pile worldwide with 28.8 percent of its supplement launches having an energy claim in 2016 and its CAGR amounting to a strong +86.7 percent.

Food Ingredients News

NZMP develops innovative fast-digesting milk protein concentrate

08 Dec 2017 --- As part of its ongoing work in the areas of proteins and medical nutrition, Fonterra’s global dairy ingredients B2B brand NZMP has launched a new milk protein concentrate (MPC) coined SureProtein Fast MPC 4868. Compared to standard milk protein offerings, the ingredient is touted as being able to provide muscles with a higher level of amino acids within the first two hours of consumption and is absorbed as quickly as whey protein.

Nutrition & Health News

Kyowa brings Setria Glutathione’s benefits to curious European consumers

05 Dec 2017 --- Following the launch of its flagship Setria Glutathione product, Kyowa Hakko is keenly watching and helping build the European market for immunity, beauty and sports nutrition products at a key time in its development. Earlier this year, the company launched its glutathione product in the European market. Manufactured through a patented fermentation process, the product can help replenish the body’s reserves of glutathione that may be depleted through poor diet, damaging lifestyle habits or aging.

Nutrition & Health News

NattoPharma enters Chinese market with new MenaQ7 launch

30 Nov 2017 --- NattoPharma has participated in a launching conference commemorating the first product introduced in China featuring MenaQ7 Vitamin K2 as MK-7. During the event, FishBurg, a Chinese dietary supplement producer in the calcium/vitamin D3 (VD3) segment, signed a partnership and supply agreement with NattoPharma and officially launched its new Blue Hat-registered calcium/VD3/MenaQ7 Vitamin K2 supplement for bone health to the Chinese market.

More Articles